Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Nurix Therapeutics' Depreciation & Amortization (CF) was $2.14 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 5.5% from $2.03 million a year earlier but down 5.1% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nurix Therapeutics' Depreciation & Amortization (CF) was $8.71 million through Aug 31, 2026, down 5.0% year-over-year; for FY2025 (ended Nov 30, 2025), it was $8.74 million, down 6.2% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 31.8% (FY2020 to FY2025).
  • In earlier fiscal years, Depreciation & Amortization (CF) was $9.32 million in FY2024 (+23.7%), $7.53 million in FY2023 (+40.8%), $5.35 million in FY2022 (+91.0%) and $2.8 million in FY2021 (+27.3%).
  • Quarterly Depreciation & Amortization (CF) has moved between $767,000 (fiscal Q4 2021) and $2.55 million (fiscal Q4 2024) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in four of the last eight quarters, with growth averaging 1.3%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was fiscal Q2 2022 (growth of 116.7%); the worst was fiscal Q4 2025 (a decline of 16.8%).
  • Per Business Quant data, NRIX's Depreciation & Amortization (CF) in the three fiscal quarters before Q3 2026 was $2.26 million (Q2 2026), $2.2 million (Q1 2026) and $2.12 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Nurix Therapeutics 1.73 Bn -891.35 Mn - 2.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 2.14 Mn
May 31, 2026 2.26 Mn
Feb 28, 2026 2.20 Mn
Nov 30, 2025 2.12 Mn
Aug 31, 2025 2.03 Mn
May 31, 2025 2.24 Mn
Feb 28, 2025 2.35 Mn
Nov 30, 2024 2.55 Mn
Aug 31, 2024 2.39 Mn
May 31, 2024 2.33 Mn
Feb 29, 2024 2.05 Mn
Nov 30, 2023 1.93 Mn
Aug 31, 2023 1.95 Mn
May 31, 2023 1.90 Mn
Feb 28, 2023 1.75 Mn
Nov 30, 2022 1.62 Mn
Aug 31, 2022 1.50 Mn
May 31, 2022 1.30 Mn
Feb 28, 2022 991,000.00
Nov 30, 2021 767,000.00
API Access

Nurix Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NRIX&period=max&api_key=YOUR_API_KEY